ANSM Clinical Investigation Authorization: regulatory review of the submission
Secure your clinical investigation authorization application with the Agence nationale de sécurité du médicament et des produits de santé (ANSM) through an expert and structured regulatory review.
Sparta Care supports you in analyzing your regulatory materials, identifying gaps, and maximizing your chances of obtaining a favorable opinion from the Agence nationale de sécurité du médicament et des produits de santé (ANSM) from the first submission.
The Challenge
An application for clinical investigation authorization for a medical device (under CE marking or already certified) is based on robust and compliant technical documentation.
The most common challenges faced by project sponsors are:
01
The identification of applicable regulatory requirements based on the nature of the medical device,
02
Consistency between the clinical investigation protocol, the technical documentation, and the regulatory strategy,
03
The quality and completeness of the documents to be submitted to the Agence nationale de sécurité du médicament et des produits de santé (ANSM),
04
Technical documentation initially prepared for an ANSM application that must be revised as part of obtaining CE marking.
Insufficient preparation can lead to significant delays and strongly impact the development timeline.
Our approach: a targeted regulatory review before ANSM submission
Sparta Care offers a comprehensive review of the regulatory materials forming your clinical investigation authorization application, prior to submission to the Agence nationale de sécurité du médicament et des produits de santé (ANSM).
Our objective is simple: to secure your application upstream by providing an expert, pragmatic review aligned with the expectations of the competent authority.
Analysis of the applicable regulatory framework
We analyze your project in order to:
- confirm the regulatory status of the medical device,
- identify the framework applicable to the clinical investigation,
- verify alignment between the clinical and regulatory strategy.
This step establishes a clear and consistent foundation for building your application documentation.
Review of the clinical investigation documentation
We review the main regulatory documents, including:
- clinical investigation protocol,
- risk analysis and safety justification,
- relevant technical documentation,
- elements related to performance and clinical benefit,
- overall consistency of the documentation submitted to the Agence nationale de sécurité du médicament et des produits de santé (ANSM).
The analysis is conducted in light of regulatory requirements and practices observed during evaluations.
Identification of gaps and areas of vulnerability
For each key element of the application, we:
- assess the level of compliance,
- identify inconsistencies or gaps,
- detect points likely to generate questions or requests for additional information from the Agence nationale de sécurité du médicament et des produits de santé (ANSM).
Gaps are prioritized according to their regulatory and operational impact.
The benefits of an ANSM review with Sparta Care
Reduced risk of rejection or requests for additional information.
Improved clarity and consistency of the documentation.
An expert external perspective on a high-stakes application.
Time savings and a pragmatic approach tailored to real-world team constraints.
Who is this service for?
Medtech startups and scale-ups preparing a first clinical investigation,
Healthcare software vendors requiring clinical validation,
Regulatory, clinical, or product teams seeking to secure their application before submission to the ANSM.